SEC Tracker
Get the app
Person · CIK 1966716

Jonathan Allan

GENERAL COUNSEL & CORP SEC at Stoke Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$2.8M
Noticed on Form 144$2M
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Stoke Therapeutics STOKCommon StockDirectly20,598Oct 2, 2026 · Filing · EDGAR

Sold and noticed by quarter

Jonathan Allan: dollars sold on Form 4 and noticed on Form 144 per quarter, Q2 2023 to Q4 2026$824K$0Q2 2023: $27K noticed on Form 144Q2 2023: $26K sold on Form 4Q3 2023: $0 noticed on Form 144Q3 2023: $0 sold on Form 4Q4 2023: $0 noticed on Form 144Q4 2023: $0 sold on Form 4Q1 2024: $73K noticed on Form 144Q1 2024: $82K sold on Form 4Q2 2024: $120K noticed on Form 144Q2 2024: $129K sold on Form 4Q3 2024: $0 noticed on Form 144Q3 2024: $0 sold on Form 4Q4 2024: $161K noticed on Form 144Q4 2024: $310K sold on Form 4Q1 2025: $0 noticed on Form 144Q1 2025: $36K sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $623K noticed on Form 144Q3 2025: $681K sold on Form 4Q4 2025: $613K noticed on Form 144Q4 2025: $824K sold on Form 4Q1 2026: $308K noticed on Form 144Q1 2026: $599K sold on Form 4Q2 2026: $44K noticed on Form 144Q2 2026: $44K sold on Form 4Q3 2026: $0 noticed on Form 144Q3 2026: $92K sold on Form 4Q4 2026: $16K noticed on Form 144Q4 2026: $17K sold on Form 4Q2 2023Q1 2024Q4 2024Q3 2025Q2 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q4 2026$17K$16K
Q3 2026$92K—
Q2 2026$44K$44K
Q1 2026$599K$308K
Q4 2025$824K$613K
Q3 2025$681K$623K
Q1 2025$36K—
Q4 2024$310K$161K
Q2 2024$129K$120K
Q1 2024$82K$73K
Q2 2023$26K$27K

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Stoke Therapeutics STOK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Nov 10, 2025 · 2 notices
Oct 2, 2026627 · ~$16KOct 2, 2026Sold as noticed Sold 627 at $26.33 on Oct 2 · $17K Form 4Filing · EDGAR
Jun 16, 20261,457 · ~$44KJun 16, 2026Sold as noticed Sold 1,457 at $29.95 on Jun 16 · $44K Form 4Filing · EDGAR
Stoke Therapeutics STOK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 12, 2024 · 6 notices
Mar 20, 20269,293 · ~$308KMar 20, 2026Partly sold Sold 8,895 in 5 sales, Mar 17 to Mar 18 · $286K likely match Form 4Filing · EDGAR
Dec 8, 20253,978 · ~$123KDec 8, 2025Partly sold Sold 3,644 in 2 sales, Dec 5 to Dec 8 · $116K likely match Form 4 (1) · Form 4 (2)Filing · EDGAR
Dec 5, 20257,781 · ~$242KDec 5, 2025Partly sold Sold 6,598 in 7 sales, Dec 2 to Dec 5 · $201K likely match Form 4 (1) · Form 4 (2)Filing · EDGAR
Oct 3, 202510,000 · ~$248KOct 3, 2025Sold as noticed Sold 10,000 at $25.07 on Oct 3 · $251K Form 4Filing · EDGAR
Aug 29, 202522,117 · ~$437KAug 29, 2025Sold as noticed Sold 22,117 in 3 sales, Aug 29 to Sep 3 · $445K Form 4Filing · EDGAR
Aug 13, 202513,712 · ~$186KAug 13, 2025Sold as noticed Sold 13,712 at $15.00 on Aug 13 · $206K Form 4Filing · EDGAR
Stoke Therapeutics STOK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 15, 2023 · 3 notices
Dec 9, 202412,114 · ~$161KDec 9, 2024Partly sold Sold 11,248 in 2 sales, Dec 6 to Dec 9 · $144K likely match Form 4 (1) · Form 4 (2)Filing · EDGAR
May 20, 20248,599 · ~$120KMay 20, 2024Sold as noticed Sold 8,599 at $15.04 on May 20 · $129K Form 4Filing · EDGAR
Mar 28, 20245,126 · ~$73KMar 28, 2024Sold as noticed Sold 5,126 in 2 sales, Mar 28 to Mar 28 · $68K Form 4Filing · EDGAR
Stoke Therapeutics STOK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 22, 2023 · 1 notice
Jun 21, 20231,948 · ~$27KJun 21, 2023Sold as noticed Sold 1,948 at $13.48 on Jun 21 · $26K Form 4Filing · EDGAR
Sales without a matching Form 144 · 11 sales
No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
———Sold without notice Stoke Therapeutics (STOK): Sold 145 at $32.47 on Aug 18, 2026 · $5KFiling · EDGAR
———Sold without notice Stoke Therapeutics (STOK): Sold 2,716 at $32.01 on Aug 18, 2026 · $87KFiling · EDGAR
———Sold without notice Stoke Therapeutics (STOK): Sold 601 at $34.41 on Mar 20, 2026 · $21K (10b5-1 plan)Filing · EDGAR
———Sold without notice Stoke Therapeutics (STOK): Sold 8,692 at $33.64 on Mar 20, 2026 · $292K (10b5-1 plan)Filing · EDGAR
———Sold without notice Stoke Therapeutics (STOK): Sold 2,678 at $32.61 on Dec 8, 2025 · $87K (10b5-1 plan)Filing · EDGAR
———Sold without notice Stoke Therapeutics (STOK): Sold 5,437 at $31.08 on Dec 5, 2025 · $169K (10b5-1 plan)Filing · EDGAR
———Sold without notice Stoke Therapeutics (STOK): Sold 1,683 at $18.24 on Aug 18, 2025 · $31KFiling · EDGAR
———Sold without notice Stoke Therapeutics (STOK): Sold 1,945 at $8.27 on Mar 19, 2025 · $16KFiling · EDGAR
———Sold without notice Stoke Therapeutics (STOK): Sold 2,266 at $8.67 on Mar 18, 2025 · $20KFiling · EDGAR
———Sold without notice Stoke Therapeutics (STOK): Sold 12,114 at $13.69 on Dec 9, 2024 · $166K (10b5-1 plan)Filing · EDGAR
———Sold without notice Stoke Therapeutics (STOK): Sold 2,349 at $6.10 on Mar 19, 2024 · $14KFiling · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Stoke Therapeutics STOK General Counsel & Corp SEC · filings 2023 to 2026 · sold $2.8M · $2M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Oct 2, 2026Sale under a 10b5-1 plan−627$26.33$17K20,598 directFiling · EDGAR
Aug 18, 2026Open-market or private sale−2,716$32.01$87K21,370 directFiling · EDGAR
Aug 18, 2026Open-market or private sale−145$32.47$5K21,225 directFiling · EDGAR
Aug 14, 2026Option or RSU exercised or converted+6,00024,086 directFiling · EDGAR
Aug 14, 2026Option or RSU exercised or converted
Performance Stock Units
−6,0000 directFiling · EDGAR
Jun 16, 2026Sale under a 10b5-1 plan−1,457$29.95$44K18,086 directFiling · EDGAR
Mar 20, 2026Sale under a 10b5-1 plan−8,692$33.64$292K20,144 directFiling · EDGAR
Mar 20, 2026Sale under a 10b5-1 plan−601$34.41$21K19,543 directFiling · EDGAR
Mar 18, 2026Open-market or private sale−4,222$31.28$132K29,242 directFiling · EDGAR
Mar 18, 2026Open-market or private sale−334$31.79$11K28,908 directFiling · EDGAR
Mar 18, 2026Open-market or private sale−72$32.85$2K28,836 directFiling · EDGAR
Mar 17, 2026Open-market or private sale−2,476$32.74$81K35,255 directFiling · EDGAR
Mar 17, 2026Open-market or private sale−1,791$33.38$60K33,464 directFiling · EDGAR
Mar 15, 2026Option or RSU exercised or converted+7,47519,731 directFiling · EDGAR
Mar 15, 2026Option or RSU exercised or converted+6,00025,731 directFiling · EDGAR
Mar 15, 2026Option or RSU exercised or converted+12,00037,731 directFiling · EDGAR
Mar 15, 2026Option or RSU exercised or converted
Restricted Stock Units
−7,4757,475 directFiling · EDGAR
Mar 15, 2026Option or RSU exercised or converted
Restricted Stock Units
−6,00012,000 directFiling · EDGAR
Mar 15, 2026Option or RSU exercised or converted
Restricted Stock Units
−12,00036,000 directFiling · EDGAR
Feb 17, 2026Grant or award from the company
Employee Stock Option (Right to Buy)
+53,00053,000 directFiling · EDGAR
Feb 17, 2026Grant or award from the company
Restricted Stock Units
+35,00035,000 directFiling · EDGAR
Dec 8, 2025Sale under a 10b5-1 plan−1,300$31.60$41K14,509 directFiling · EDGAR
Dec 8, 2025Sale under a 10b5-1 plan−2,678$32.61$87K11,831 directFiling · EDGAR
Dec 5, 2025Sale under a 10b5-1 plan−1,004$31.33$31K23,590 directFiling · EDGAR
Dec 5, 2025Sale under a 10b5-1 plan−5,437$31.08$169K18,153 directFiling · EDGAR
Dec 5, 2025Sale under a 10b5-1 plan−2,344$31.76$74K15,809 directFiling · EDGAR
Dec 4, 2025Sale under a 10b5-1 plan−824$30.76$25K24,788 directFiling · EDGAR
Dec 4, 2025Sale under a 10b5-1 plan−194$31.32$6K24,594 directFiling · EDGAR
Dec 3, 2025Option or RSU exercised or converted+6,00025,612 directFiling · EDGAR
Dec 3, 2025Option or RSU exercised or converted
Performance Stock Units
−6,0000 directFiling · EDGAR
Dec 3, 2025Open-market or private sale−898$30.34$27K21,006 directFiling · EDGAR
Dec 3, 2025Open-market or private sale−1,394$30.85$43K19,612 directFiling · EDGAR
Dec 2, 2025Open-market or private sale−1,416$29.56$42K22,772 directFiling · EDGAR
Dec 2, 2025Open-market or private sale−868$30.14$26K21,904 directFiling · EDGAR
Dec 1, 2025Option or RSU exercised or converted+12,35724,188 directFiling · EDGAR
Dec 1, 2025Option or RSU exercised or converted
Restricted Stock Units
−12,3570 directFiling · EDGAR
Oct 3, 2025Option or RSU exercised or converted+10,000$9.15$92K21,831 directFiling · EDGAR
Oct 3, 2025Sale under a 10b5-1 plan−10,000$25.07$251K11,831 directFiling · EDGAR
Oct 3, 2025Option or RSU exercised or converted
Stock Option (Right to Buy)
−10,00034,800 directFiling · EDGAR
Sep 3, 2025Sale under a 10b5-1 plan−6,345$20.07$127K11,831 directFiling · EDGAR
Sep 2, 2025Option or RSU exercised or converted+9,150$7.07$65K33,098 directFiling · EDGAR
Sep 2, 2025Sale under a 10b5-1 plan−14,922$20.14$300K18,176 directFiling · EDGAR
Sep 2, 2025Option or RSU exercised or converted
Stock Option (Right to Buy)
−9,15015,801 directFiling · EDGAR
Aug 29, 2025Option or RSU exercised or converted+850$7.07$6K24,798 directFiling · EDGAR
Aug 29, 2025Sale under a 10b5-1 plan−850$20.00$17K23,948 directFiling · EDGAR
Aug 29, 2025Option or RSU exercised or converted
Stock Option (Right to Buy)
−85024,951 directFiling · EDGAR
Aug 18, 2025Open-market or private sale−1,683$18.24$31K23,948 directFiling · EDGAR
Aug 14, 2025Option or RSU exercised or converted+6,00025,631 directFiling · EDGAR
Aug 14, 2025Grant or award from the company
Performance Stock Units
+12,00012,000 directFiling · EDGAR
Aug 14, 2025Option or RSU exercised or converted
Performance Stock Units
−6,0006,000 directFiling · EDGAR
Aug 13, 2025Sale under a 10b5-1 plan−13,712$15.00$206K19,631 directFiling · EDGAR
Mar 20, 2025Grant or award from the company
Employee Stock Option (Right to Buy)
+72,00072,000 directFiling · EDGAR
Mar 20, 2025Grant or award from the company
Restricted Stock Units
+48,00048,000 directFiling · EDGAR
Mar 19, 2025Open-market or private sale−1,945$8.27$16K31,565 directFiling · EDGAR
Mar 18, 2025Open-market or private sale−2,266$8.67$20K33,510 directFiling · EDGAR
Mar 15, 2025Option or RSU exercised or converted+7,47529,776 directFiling · EDGAR
Mar 15, 2025Option or RSU exercised or converted+6,00035,776 directFiling · EDGAR
Mar 15, 2025Option or RSU exercised or converted
Restricted Stock Units
−7,47514,950 directFiling · EDGAR
Mar 15, 2025Option or RSU exercised or converted
Restricted Stock Units
−6,00018,000 directFiling · EDGAR
Dec 9, 2024Sale under a 10b5-1 plan−12,114$13.69$166K23,028 directFiling · EDGAR

23 earlier transactions are in the filing list below.

All 41 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Oct 2, 2026Form 4Stoke Therapeutics STOKFiling · EDGAR
Oct 2, 2026Form 144Stoke Therapeutics STOKFiling · EDGAR
Aug 18, 2026Form 4Stoke Therapeutics STOKFiling · EDGAR
Jun 18, 2026Form 4Stoke Therapeutics STOKFiling · EDGAR
Jun 16, 2026Form 144Stoke Therapeutics STOKFiling · EDGAR
Mar 24, 2026Form 4Stoke Therapeutics STOKFiling · EDGAR
Mar 20, 2026Form 144Stoke Therapeutics STOKFiling · EDGAR
Mar 19, 2026Form 4Stoke Therapeutics STOKFiling · EDGAR
Mar 17, 2026Form 4Stoke Therapeutics STOKFiling · EDGAR
Feb 19, 2026Form 4Stoke Therapeutics STOKFiling · EDGAR
Dec 10, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Dec 8, 2025Form 144Stoke Therapeutics STOKFiling · EDGAR
Dec 5, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Dec 5, 2025Form 144Stoke Therapeutics STOKFiling · EDGAR
Dec 3, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Oct 7, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Oct 3, 2025Form 144Stoke Therapeutics STOKFiling · EDGAR
Sep 3, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Aug 29, 2025Form 144Stoke Therapeutics STOKFiling · EDGAR
Aug 20, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Aug 18, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Aug 15, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Aug 13, 2025Form 144Stoke Therapeutics STOKFiling · EDGAR
Mar 20, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Mar 18, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Dec 11, 2024Form 4Stoke Therapeutics STOKFiling · EDGAR
Dec 10, 2024Form 4Stoke Therapeutics STOKFiling · EDGAR
Dec 9, 2024Form 144Stoke Therapeutics STOKFiling · EDGAR
Dec 5, 2024Form 4Stoke Therapeutics STOKFiling · EDGAR
Dec 3, 2024Form 4Stoke Therapeutics STOKFiling · EDGAR
Jun 7, 2024Form 4Stoke Therapeutics STOKFiling · EDGAR
May 22, 2024Form 4Stoke Therapeutics STOKFiling · EDGAR
May 20, 2024Form 144Stoke Therapeutics STOKFiling · EDGAR
Apr 1, 2024Form 4Stoke Therapeutics STOKFiling · EDGAR
Mar 28, 2024Form 144Stoke Therapeutics STOKFiling · EDGAR
Mar 19, 2024Form 4Stoke Therapeutics STOKFiling · EDGAR
Dec 5, 2023Form 4Stoke Therapeutics STOKFiling · EDGAR
Jun 23, 2023Form 4Stoke Therapeutics STOKFiling · EDGAR
Jun 21, 2023Form 144Stoke Therapeutics STOKFiling · EDGAR
Mar 17, 2023Form 4Stoke Therapeutics STOKFiling · EDGAR
Mar 17, 2023Form 3Stoke Therapeutics STOKFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.